Article: Immunomedics Kicked Out of Prestigious ASCO Cancer Conference

Article - Media

Immunomedics Kicked Out of Prestigious ASCO Cancer Conference

Adam Feuerstein

TheStreet, 3 June 2016

Immunomedics (IMMU) – Get Report was caught trying to sneak old, previously presented clinical data on its triple-negative breast cancer drug IMMU-132 into the American Society of Clinical Oncology (ASCO) annual meeting, which starts Friday.

Read full article.

 

Comment: Complete fraud.  Stock went from $5.50 to $2.50 on millions of shares, then up to $27.

THE DOLLAR HAS NO INTRINSIC VALUE : DO YOUR ASSETS?